Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




MRI Program Developed to Advance Research

By Biotechdaily staff writers
Posted on 17 Sep 2007
A new U.S. More...
magnetic resonance imaging (MRI) research program has been developed to further the study of disease processes.

When powerful magnets line up the body's protons before radiofrequency waves can snatch their attention away, the mechanism is called spin physics. When signals generated by the movement are mathematically transformed into dramatic images of hearts, lungs, and other organs, the technique is called MRI.

"Protons normally would be pointing in many different directions,” said Dr. Tom Hu, director of the Small Animal Imaging Program at the Medical College of Georgia (MCG; Augusta, USA). "But if you put an object in the MRI, the magnet will line up the protons and what that does is generate the original, steady state. Then, by applying different radiofrequencies, pretty much like what you do with a car antenna, you can pursue radiofrequencies to perturb the system and you pretty much listen to it.”

When Dr. Hu, a biochemist and biophysicist, utilizes MRI scanning to see how calcium travels in and out of heart cells as the heart contracts and relaxes, and how that movement does not work so well in heart failure, a disorder resulting in oversized hearts with difficulty beating. Dr. Hu is trying to determine whether the metallic manganese ion, which can travel in the same manner as calcium, can enhance the signal and subsequent images he gets of how calcium cannot get back into cells after a heart attack.

The MRI that is the program's centerpiece looks like the human version except the cylinder the patient lies in is much smaller. However, it has a stronger magnet than the usual clinical grade units mainly because the organs of interest are so much smaller, according to Dr. Nathan Yanasak, an MRI scientist.

Many conventional MRI units are 1.5 Tesla and high-end clinical units are 3 Tesla, a measure of the density and intensity of a magnetic field. MCG's small animal MRI unit is 7 Tesla, not the strongest magnet available for research but one that enables good quality images of small organs comparable to those obtained by clinical machines.

Similar to what physicians do with patients, research scientists now use technology to help track disease progression over time and even to see if treatments work. In his own work, for example, Dr. Hu assesses development of heart failure by monitoring changes in calcium dynamic and heart structure.

Newer technology, on loan to the facility from Xenogen Corp. (Cranbury, NJ, USA), part of Caliber Life Sciences Corp., has enabled the lab to add genetic expression into the technology. The optical scanning system uses luciferase, the same enzyme fireflies use to glow, to identify gene expression.

The number of MCG scientists using the facility is considerable and increasing, according to its director. One MCG scientist, for example, is looking at blood flow in the brain of her diabetes model, and another is looking at stroke event and recovery.


Related Links:
Xenogen
Medical College of Georgia

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Blood Ammonia Test Analyzer
DRI-CHEM NX10N
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.